Early-Onset Bowel Cancer Study Reveals Distinct Biological and Clinical Features in Younger Adults
A significant study, led by Flinders University and Flinders Medical Center in Australia, has identified crucial differences in bowel cancer diagnosed in individuals aged 50 or younger compared to those diagnosed after 50. Published in the Medical Journal of Australia, the research analyzed data from 1,691 Australians with advanced bowel cancer that had spread to the liver. The findings indicate that younger patients exhibit distinct tumor biology, disease characteristics, and survival outcomes. Specifically, younger patients are more likely to be women, have tumors on the left side of the bowel, and possess certain genetic mutations. They also demonstrated longer overall survival after the cancer had spread to the liver. The study also highlighted that specific genetic mutations, BRAF and KRAS, are associated with poorer outcomes across both age groups, emphasizing the growing importance of genetic testing. 
